Trial intelligence / Profile preview

Short vs Long Course Doxycycline in COPD Exacerbation

NCT00952861Phase 4Withdrawn

Sponsor
University Hospital Odense
Start
Oct 2009
Primary completion
Oct 2010
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised, double-blind trial in chronic obstructive pulmonary disease (COPD) comparing Doxycycline with Placebo (2 arms). Primary endpoint: 6 minutes walking distance at Day 14. Planned start Oct 2009; status: withdrawn.

02

Drugs

doxycycline
03

Conditions

chronic obstructive pulmonary disease (COPD)

Beyond the preview

Go deeper on NCT00952861.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00952861.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call